Can engineered immune cells tame autoimmune disease?
Disease control
Recruiting now
This early-phase trial is testing whether a single infusion of engineered immune cells, called CAR NK cells, can safely and effectively treat people with moderate to severe autoimmune diseases that have not improved with standard treatment. The study will enroll 15 adults and wil…
Phase: EARLY_PHASE1 • Sponsor: YANRU WANG • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC